Advancing vaccine development through green biotechnology

The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year.

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol – Biotech Investments

Rancho Cucamonga, 05/22/2024 / 06:00, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals,

May 23, 2024

Cardiovascular burden of TTR gene variant among Black carriers across mid to late-life

The key contribution of this study was to provide more accurate estimates of cardiovascular risk across mid to late life, compared to previously existing analyses.

May 15, 2024

ImmunoGen, ImmunoBiochem partner for ADCs development

ImmunoGen and ImmunoBiochem will work together to develop next-generation antibody-drug conjugates. Credit: Alpha Tauri 3D Graphics. ImmunoGen has signed a multi-target licence and option agreement

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.